Neurologic toxicity management with BRMs.
Shelton
B N
BN
Critical Care Institute, Johns Hopkins Oncology Center, Baltimore, MD.
Sargent
C A
CA
D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000451:nursing; D009730:Nursing Assessment
D007155:Immunologic Factors